CE
Celcuity Inc.
CELC · NASDAQ
$82.70 -1.14% (-$0.95)
1M -9.73%
Market Cap $4.07B
P/E Ratio -
Div. Yield -
ROE 350.78%
Bulios Fair Price
$51.61
37.6% downside
Current Price
$82.7
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CELC is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
-
N/A P/FCF N/A
P/E N/A
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 9.08%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 27.35%
ROIC 28.14%
Asset turnover 0.00x
Debt
43 /100
Moderate Int. coverage -5.29x
Current ratio 8.93x
Debt/Assets N/A
Stability
41 /100
Moderate Profitable years 0
Beta 0.16x
EPS volatility 17.93%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CELC
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Brian F. Sullivan
Employees
155
Headquarters
Minneapolis
Upcoming events
11 NOV
Earnings
Upcoming earnings report